CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) Stock Fundamental Analysis
NASDAQ:CCLDO - Nasdaq - US14167R3084 - Currency: USD
CCLDO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. CCLDO has an excellent financial health rating, but there are some minor concerns on its profitability. CCLDO has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CCLDO had negative earnings in the past year.
CCLDO had a positive operating cash flow in the past year.
In the past 5 years CCLDO always reported negative net income.
CCLDO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.02%, CCLDO belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
CCLDO has a better Return On Equity (0.02%) than 82.86% of its industry peers.
With an excellent Return On Invested Capital value of 16.12%, CCLDO belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROIC | 16.12% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of CCLDO (0.01%) is better than 82.86% of its industry peers.
CCLDO has a Operating Margin of 10.77%. This is amongst the best in the industry. CCLDO outperforms 88.57% of its industry peers.
CCLDO's Operating Margin has improved in the last couple of years.
The Gross Margin of CCLDO (46.00%) is worse than 68.57% of its industry peers.
In the last couple of years the Gross Margin of CCLDO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCLDO is still creating some value.
The number of shares outstanding for CCLDO has been increased compared to 1 year ago.
The number of shares outstanding for CCLDO has been increased compared to 5 years ago.
CCLDO has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 28.72 indicates that CCLDO is not in any danger for bankruptcy at the moment.
CCLDO has a Altman-Z score of 28.72. This is amongst the best in the industry. CCLDO outperforms 94.29% of its industry peers.
The Debt to FCF ratio of CCLDO is 0.02, which is an excellent value as it means it would take CCLDO, only 0.02 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.02, CCLDO belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that CCLDO is not too dependend on debt financing.
The Debt to Equity ratio of CCLDO (0.00) is better than 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Altman-Z | 28.72 |
ROIC/WACC1.51
WACC10.66%
2.3 Liquidity
CCLDO has a Current Ratio of 1.91. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
CCLDO's Current ratio of 1.91 is in line compared to the rest of the industry. CCLDO outperforms 45.71% of its industry peers.
A Quick Ratio of 1.88 indicates that CCLDO should not have too much problems paying its short term obligations.
CCLDO has a Quick ratio of 1.88. This is comparable to the rest of the industry: CCLDO outperforms 48.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 |
3. Growth
3.1 Past
CCLDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.92%, which is quite impressive.
The Revenue has been growing slightly by 0.04% in the past year.
Measured over the past years, CCLDO shows a quite strong growth in Revenue. The Revenue has been growing by 11.47% on average per year.
EPS 1Y (TTM)98.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.53%
3.2 Future
CCLDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.81% yearly.
The Revenue is expected to grow by 4.18% on average over the next years.
EPS Next Y151%
EPS Next 2Y67.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.95%
Revenue Next 2Y4.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CCLDO. In the last year negative earnings were reported.
CCLDO is valuated quite expensively with a Price/Forward Earnings ratio of 128.19.
CCLDO's Price/Forward Earnings is on the same level as the industry average.
CCLDO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 33.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 128.19 |
4.2 Price Multiples
CCLDO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CCLDO is cheaper than 65.71% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCLDO is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.84 | ||
| EV/EBITDA | 34.56 |
4.3 Compensation for Growth
CCLDO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CCLDO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CCLDO's earnings are expected to grow with 67.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.81%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.87%, CCLDO is a good candidate for dividend investing.
CCLDO's Dividend Yield is rather good when compared to the industry average which is at 5.92. CCLDO pays more dividend than 97.14% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, CCLDO pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.87% |
5.2 History
On average, the dividend of CCLDO grows each year by 21.20%, which is quite nice.
CCLDO has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)21.2%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The dividend of CCLDO is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y67.81%
EPS Next 3YN/A
CARECLOUD INC - CCLD 8 3/4 PERP
NASDAQ:CCLDO (8/12/2025, 2:37:07 PM)
20.92
+0.07 (+0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners16.98%
Inst Owner ChangeN/A
Ins Owners14.3%
Ins Owner ChangeN/A
Market Cap885.33M
Analysts80
Price Target38.25 (82.84%)
Short Float %0.01%
Short Ratio0.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.87% |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)132.35%
Min EPS beat(2)21.57%
Max EPS beat(2)243.14%
EPS beat(4)4
Avg EPS beat(4)109.05%
Min EPS beat(4)21.57%
Max EPS beat(4)243.14%
EPS beat(8)5
Avg EPS beat(8)18.26%
EPS beat(12)8
Avg EPS beat(12)10.78%
EPS beat(16)12
Avg EPS beat(16)20.76%
Revenue beat(2)1
Avg Revenue beat(2)2.17%
Min Revenue beat(2)-1.26%
Max Revenue beat(2)5.6%
Revenue beat(4)1
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)5.6%
Revenue beat(8)1
Avg Revenue beat(8)-2.29%
Revenue beat(12)1
Avg Revenue beat(12)-3.19%
Revenue beat(16)3
Avg Revenue beat(16)-2.21%
PT rev (1m)11.45%
PT rev (3m)-14.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)224.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 128.19 | ||
| P/S | 7.92 | ||
| P/FCF | 50.84 | ||
| P/OCF | 35.68 | ||
| P/B | 15.79 | ||
| P/tB | 41.43 | ||
| EV/EBITDA | 34.56 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.16
Fwd EY0.78%
FCF(TTM)0.41
FCFY1.97%
OCF(TTM)0.59
OCFY2.8%
SpS2.64
BVpS1.33
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROCE | 20.4% | ||
| ROIC | 16.12% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 39.14% | ||
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% | ||
| FCFM | 15.58% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y52.71%
ROICexcg growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score7
Asset Turnover1.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 54.79% | ||
| Cap/Sales | 6.62% | ||
| Interest Coverage | 63.03 | ||
| Cash Conversion | 97.14% | ||
| Profit Quality | 124386% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 | ||
| Altman-Z | 28.72 |
F-Score7
WACC10.66%
ROIC/WACC1.51
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y151%
EPS Next 2Y67.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.53%
Revenue Next Year0.95%
Revenue Next 2Y4.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15735.1%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year208.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.11%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y21.45%
OCF growth 3Y15.69%
OCF growth 5Y22.06%